Jeff Yass’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
Other funds holding GANX
PCM
Jeff Yass's GANX Position: Q3 2026 in Review
Jeff Yass sold out of Gain Therapeutics (GANX) in Q3 2026, closing a stake of 78,206 shares — an estimated $143K sold.
Jeff Yass first reported a position in GANX in Q4 2021 and held it in 13 quarters. The position peaked at $2.2M in Q4 2025. 50 funds tracked by Wall St. Rank hold GANX as of Q3 2026.
- Jeff Yass reported no remaining Gain Therapeutics position as of Q3 2026 after selling out during the quarter.
- Jeff Yass sold 78,206 Gain Therapeutics shares in Q3 2026, an estimated $143K.
- Jeff Yass first reported a position in Gain Therapeutics in Q4 2021 and held it in 13 quarters.
- Jeff Yass's Gain Therapeutics position peaked at $2.2M in Q4 2025.
- 50 funds tracked by Wall St. Rank held Gain Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.